Palvella Therapeutics, Inc. (PVLA) Total Assets by Year
Palvella Therapeutics, Inc. closed fiscal year 2025 with $59.6M in total assets, $31.6M in total liabilities and $28.0M in shareholder equity. This represents a decrease of 32.5% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Palvella Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PVLA Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $59.6M-32.5% | $88.2M+1069.0% | $7.5M-92.1% | $95.5M-37.8% | $153.6M+46.2% | $105.0M-25.6% | $141.1M-0.2% | $141.3M+36.1% | $103.9M+196.3% | $35.1M+3.3% | $34.0M+55.3% | $21.9M+200.4% | $7.3M |
| Total Liabilities | $31.6M+23.2% | $25.6M-68.8% | $82.0M-56.7% | $189.3M+84.1% | $102.8M+39.0% | $74.0M-17.6% | $89.7M-11.5% | $101.4M+9.8% | $92.4M+838.9% | $9.8M+248.6% | $2.8M-26.7% | $3.9M-42.4% | $6.7M |
| Total Equity | $28.0M-55.3% | $62.6M+184.1% | -$74.5M+20.6% | -$93.8M-284.8% | $50.8M+63.6% | $31.0M-39.6% | $51.4M+28.6% | $39.9M+246.6% | $11.5M-54.3% | $25.2M-19.0% | $31.1M+72.9% | $18.0M+2978.0% | $585K |
PVLA Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $253.5M+243.8% | $263.8M+232.0% | $59.6M-32.5% | $66.9M+226.2% | $73.7M+194.4% | $79.4M+169.3% | $88.2M+1069.0% | $20.5M-65.4% | $25.1M-71.4% | $29.5M-64.1% | $7.5M-92.1% | $59.4M-40.1% |
| Total Liabilities | $36.6M+41.1% | $31.4M+31.8% | $31.6M+23.2% | $28.3M-73.8% | $26.0M-75.5% | $23.9M-77.6% | $25.6M-68.8% | $107.9M+273.9% | $105.9M+125.1% | $106.4M+59.2% | $82.0M-56.7% | $28.9M-54.5% |
| Total Equity | $216.9M+353.9% | $232.3M+318.0% | $28.0M-55.3% | $38.7M+144.3% | $47.8M+159.1% | $55.6M+172.3% | $62.6M+184.1% | -$87.4M-386.5% | -$80.8M-299.6% | -$76.9M-597.3% | -$74.5M+20.6% | $30.5M-14.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Palvella Therapeutics, Inc. financials
Frequently Asked Questions
What was Palvella Therapeutics, Inc.'s total assets in fiscal year 2025?
Palvella Therapeutics, Inc. closed fiscal year 2025 with $59.6M in total assets, $31.6M in total liabilities and $28.0M in shareholder equity.
How fast is Palvella Therapeutics, Inc.'s total assets growing?
Palvella Therapeutics, Inc. (PVLA) total assets fell by 32.5% year over year, from $88.2M to $59.6M in fiscal year 2025.
How has Palvella Therapeutics, Inc.'s total assets changed over the years?
Across the 13 fiscal years this page covers, Palvella Therapeutics, Inc. (PVLA) total assets went from $7.3M in fiscal year 2013 to $59.6M in fiscal year 2025.
What was Palvella Therapeutics, Inc.'s total assets in the most recent quarter?
Palvella Therapeutics, Inc. (PVLA) reported $253.5M in total assets in Q2 2026. This represents an increase of 243.8% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Palvella Therapeutics, Inc. (PVLA) reported on that line in every period on record.